| Cumulative incidence of and predictive factors for lung cancer in IPF Y Ozawa, T Suda, T Naito, N Enomoto, D Hashimoto, T Fujisawa, ... Respirology 14 (5), 723-728, 2009 | 294 | 2009 |
| Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases T Suda, Y Kaida, Y Nakamura, N Enomoto, T Fujisawa, S Imokawa, ... Respiratory medicine 103 (6), 846-853, 2009 | 253 | 2009 |
| Prognostic impact of circulating tumor cells in patients with small cell lung cancer T Naito, F Tanaka, A Ono, K Yoneda, T Takahashi, H Murakami, ... Journal of Thoracic Oncology 7 (3), 512-519, 2012 | 221 | 2012 |
| Higher Sensitivity and Specificity for Diffusion-weighted Imaging of Malignant Lung Lesions without Apparent Diffusion Coefficient Quantification1 T Uto, Y Takehara, Y Nakamura, T Naito, D Hashimoto, N Inui, T Suda, ... Radiology 252 (1), 247-254, 2009 | 208 | 2009 |
| The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer H Kenmotsu, T Naito, M Kimura, A Ono, T Shukuya, Y Nakamura, A Tsuya, ... Journal of Thoracic Oncology 6 (7), 1242-1246, 2011 | 205 | 2011 |
| Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system M Hosokawa, H Kenmotsu, Y Koh, T Yoshino, T Yoshikawa, T Naito, ... PloS one 8 (6), e67466, 2013 | 193 | 2013 |
| Anamorelin (ONO‐7643) for the treatment of patients with non–small cell lung cancer and cachexia: Results from a randomized, double‐blind, placebo‐controlled, multicenter study … N Katakami, J Uchino, T Yokoyama, T Naito, M Kondo, K Yamada, ... Cancer 124 (3), 606-616, 2018 | 184 | 2018 |
| Interstitial lung diseases associated with amyopathic dermatomyositis T Suda, T Fujisawa, N Enomoto, Y Nakamura, N Inui, T Naito, ... European Respiratory Journal 28 (5), 1005-1012, 2006 | 175 | 2006 |
| Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer M Kimura, T Naito, H Kenmotsu, T Taira, K Wakuda, T Oyakawa, ... Supportive Care in Cancer 23, 1699-1708, 2015 | 172 | 2015 |
| Efficacy of gefitinib for non‐adenocarcinoma non‐small‐cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports T Shukuya, T Takahashi, R Kaira, A Ono, Y Nakamura, A Tsuya, ... Cancer science 102 (5), 1032-1037, 2011 | 169 | 2011 |
| Biologic Correlation of 2-[18F]-Fluoro-2-Deoxy-D-Glucose Uptake on Positron Emission Tomography in Thymic Epithelial Tumors K Kaira, M Endo, M Abe, K Nakagawa, Y Ohde, T Okumura, T Takahashi, ... Journal of clinical oncology 28 (23), 3746-3753, 2010 | 164 | 2010 |
| Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non‐small‐cell lung cancer T Naito, S Mitsunaga, S Miura, N Tatematsu, T Inano, T Mouri, T Tsuji, ... Journal of cachexia, sarcopenia and muscle 10 (1), 73-83, 2019 | 135 | 2019 |
| Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis K Kaira, Y Horie, E Ayabe, H Murakami, T Takahashi, A Tsuya, ... Journal of Thoracic Oncology 5 (4), 460-465, 2010 | 130 | 2010 |
| A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia S Hamauchi, J Furuse, T Takano, Y Munemoto, K Furuya, H Baba, ... Cancer 125 (23), 4294-4302, 2019 | 117 | 2019 |
| Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure T Shukuya, T Takahashi, T Naito, R Kaira, A Ono, Y Nakamura, A Tsuya, ... Lung Cancer 74 (3), 457-461, 2011 | 111 | 2011 |
| Microcavity array system for size-based enrichment of circulating tumor cells from the blood of patients with small-cell lung cancer M Hosokawa, T Yoshikawa, R Negishi, T Yoshino, Y Koh, H Kenmotsu, ... Analytical chemistry 85 (12), 5692-5698, 2013 | 107 | 2013 |
| Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4) H Murakami, T Tamura, T Takahashi, H Nokihara, T Naito, Y Nakamura, ... Cancer chemotherapy and pharmacology 69, 891-899, 2012 | 97 | 2012 |
| LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer K Kaira, N Oriuchi, T Takahashi, K Nakagawa, Y Ohde, T Okumura, ... American journal of translational research 3 (5), 468, 2011 | 94 | 2011 |
| Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma S Igawa, H Murakami, T Takahashi, Y Nakamura, A Tsuya, T Naito, ... Lung Cancer 67 (2), 194-197, 2010 | 93 | 2010 |
| Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA K Suzuki, T Suda, T Naito, K Ide, K Chida, H Nakamura American journal of respiratory and critical care medicine 171 (7), 707-713, 2005 | 93 | 2005 |
